GEN Exclusives

More »

GEN News Highlights

Back to Item »

J&J to Initially Spend $1.5B for Elan’s Alzheimer’s Immunotherapy Program

J&J is buying a $1 billion stake in Elan and creating a new firm seeded with $500 million to continue R&D.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Climate Change

How would you describe the researchers response to the 2°C global temperature target?

More »